Vimarsana
Biggest News Aggregation in the World

Precision Pathology Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Pathology Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Pathology Services Today - Breaking & Trending Today

BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

BioAffinity Technologies, Inc. , a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease, today reported financial results for...

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

SAN ANTONIO--(BUSINESS WIRE)--Apr 1, 2024--

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and six months ended June 30, 2023, and provided a...

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer | Business - Vimarsana News

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer | Business

SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer - Vimarsana News

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer

BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that the American Medical Association has released...